Above the 40 (June 1, 2018) – Uncomfortable Divergences Weigh On the Stock Market’s Manic Rally

AT40 = 62.5% of stocks are trading above their respective 40-day moving averages (DMAs) AT200 = 52.7% of stocks are trading above their respective 200DMAs (a near 4-month high) VIX = 13.5 (down 12.8%) Short-term Trading Call: neutral Commentary A day like this past Friday makes me want to be bullish about the entire stock … Read more

Above the 40 (May 11, 2018) – The Stock Market’s Time to Test Buyers’ Resolve

AT40 = 65.3% of stocks are trading above their respective 40-day moving averages (DMAs) AT200 = 51.5% of stocks are trading above their respective 200DMAs VIX = 12.7 Short-term Trading Call: neutral Commentary Here we are again. The stock market looks like it is breaking free, but there are major caveats which keep me wary … Read more

Lessons from the DexCom Breakout

Five months ago, I made the case for bottom-fishing in DexCom (DXCM) following the news of competitor’s Abbott (ABT) product approval. The trade was looking shaky a few weeks later when the stock made a minor new closing low from that price collapse. November earnings produced the catalyst to confirm the bottom, and the stock … Read more

Morgan Stanley Turns In A Strong Report Card On Speculation

At the beginning of the year, I drew up a list of stocks that Morgan Stanley (MS) recently included in 13G filings to disclose significant stakes. My interest was sparked by a surprising stake in Xunlei Limited (XNET), and I was further surprised to find a notable list of speculative stakes by Morgan. Now that … Read more

Above the 40 (February 15, 2016) – S&P 500 Passes A Key Post Oversold Test

AT40 = 31.6% of stocks are trading above their respective 40-day moving averages (DMAs) AT200 = 49.5% of stocks are trading above their respective 200DMAs VIX = 19.1 Short-term Trading Call: bullish Commentary The S&P 500 (SPY) joined the NASDAQ and PowerShares QQQ ETF (QQQ) by closing above its 50-day moving average (DMA). The move … Read more